BXP's $1.2 Billion 343 Madison Loan Advances a Major Growth Project

BXP Locks in Major Project Financing

The facility represents 60% loan-to-cost financing and carries a four-year initial term plus a one-year extension option. Its initial rate is Term SOFR plus 2.50%, declining to SOFR plus 2.25% after specified leasing and construction milestones.

That structure gives BXP committed project financing while linking a lower borrowing spread to execution. The loan supports construction of the approximately 930,000-square-foot development and marks a major capitalization step for the project.

BXP Reduces Its Remaining Equity Commitment

Closing the loan reduced BXP's expected future equity spending on 343 Madison to about $341 million. That lowers the amount of additional company capital required for what management described as BXP's largest development underway.

The financing also fits BXP's broader capital strategy. The company is using project financing, asset sales and other funding sources while pursuing a lower leverage objective and continuing to fund development commitments.

BXP Still Needs More Leasing at 343 Madison

343 Madison was about 50% pre-leased, helped by an approximately 148,000-square-foot commitment from McDermott Will & Schulte. Management also indicated negotiations were underway for another 18% of the building, leaving future leasing as a key execution measure.

SL Green Realty Corp. SLG, Manhattan's largest office landlord, provides a useful read-through on demand for high-quality New York office space. Vornado Realty Trust VNO, which owns and operates nearly 20 million square feet of prime office properties, offers another relevant gauge of Manhattan leasing conditions.

Shares of BXP have risen 13.4% over the past three months, which underperformed both SLG and VNO.

Image Source: Zacks Investment Research

BXP Targets Attractive Returns From the Project

Management expects a 7.5%-8% stabilized return on cost for 343 Madison. The project is scheduled for late-2029 delivery, so achieving that return will depend on construction staying on track and additional leasing being completed on acceptable economics.

The construction loan materially advances the funding plan but does not remove development risk. Leasing milestones can improve revenue visibility, while delays, cost pressure or slower absorption could affect the timing and level of returns before stabilization.

BXP's Broader Pipeline Raises the Stakes

343 Madison sits within an active development and redevelopment pipeline spanning about 3.5 million square feet and $3.2 billion of BXP investment. About $2.1 billion remained to be spent, while the office portion was 65% leased.

Together with recently delivered assets that are not yet stabilized, the pipeline is projected to contribute about $310 million to BXP's share of cash net operating income upon stabilization. That makes execution across the portfolio an important long-term earnings driver.

BXP's Mixed Scores Keep Expectations Balanced

The $1.2 billion loan meaningfully reduces funding uncertainty at 343 Madison, but the event is one step in a multi-year development process. Investors still have to weigh remaining equity needs, lease-up progress and construction execution before the project reaches stabilization.

BXP currently carries a Zacks Rank #3 (Hold). It has a VGM Score of B, Value Score of B and Momentum Score of B, while its Growth Score is D. The B scores indicate favorable value and momentum characteristics, but the #3 Rank and weaker Growth Score support a measured view rather than a stronger near-term signal. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Research Chief Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research